Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-206540

Chief Executive Officer sold 40,000 shares at $50.10 ($2,003,860)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2026-05-01 Sale 10b5-1 −40,000 $50.10 $2,003,860 2,878,326 I
Open-market sales · 40,000 sh · avg $50.10 · $2,003,860
Loading xslF345X06/ownership.xml…